These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30975400)

  • 21. Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values.
    Rand-Hendriksen K; Ramos-Goñi JM; Augestad LA; Luo N
    Value Health; 2017; 20(7):945-952. PubMed ID: 28712624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores.
    McClure NS; Sayah FA; Xie F; Luo N; Johnson JA
    Value Health; 2017 Apr; 20(4):644-650. PubMed ID: 28408007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health gap for multimorbidity: comparison of models combining uniconditional health gap.
    Park B; Ock M; Jo MW; Lee HA; Lee EK; Park B; Park H
    Qual Life Res; 2020 Sep; 29(9):2475-2483. PubMed ID: 32562196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating Health State Utility Values for Comorbidities.
    Ara R; Brazier J
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):89-94. PubMed ID: 29052158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating.
    Thompson NR; Lapin BR; Katzan IL
    Pharmacoeconomics; 2017 Nov; 35(11):1167-1176. PubMed ID: 28710740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Social Care Needs and Well-Being Be Explained by the EQ-5D? Analysis of the Health Survey for England.
    Singh J; Pokhrel S; Longworth L
    Value Health; 2018 Jul; 21(7):830-838. PubMed ID: 30005755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining the relationship between health-related quality of life and increasing numbers of diagnoses.
    Barra M; Augestad LA; Whitehurst DG; Rand-Hendriksen K
    Qual Life Res; 2015 Dec; 24(12):2823-32. PubMed ID: 26068730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People's Quality of Life Brief Questionnaire (OPQoL-Brief) Scores.
    Kaambwa B; Ratcliffe J
    Patient; 2018 Feb; 11(1):39-54. PubMed ID: 28623629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values.
    Hernández Alava M; Wailoo AJ; Ara R
    Value Health; 2012 May; 15(3):550-61. PubMed ID: 22583466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing utility values for the 22-item Sino-Nasal Outcome Test (SNOT-22) using a crosswalk to the EuroQol-five-dimensional questionnaire-three-level version (EQ-5D-3L).
    Crump RT; Lai E; Liu G; Janjua A; Sutherland JM
    Int Forum Allergy Rhinol; 2017 May; 7(5):480-487. PubMed ID: 28182331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility scores for the Health Utilities Index Mark 2: an empirical assessment of alternative mapping functions.
    McCabe CJ; Stevens KJ; Brazier JE
    Med Care; 2005 Jun; 43(6):627-35. PubMed ID: 15908858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysis.
    Buchanan-Hughes AM; Buti M; Hanman K; Langford B; Wright M; Eddowes LA
    Qual Life Res; 2019 Feb; 28(2):297-319. PubMed ID: 30225787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.
    Sullivan PW; Ghushchyan V
    Med Decis Making; 2006; 26(4):401-9. PubMed ID: 16855128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
    Jia H; Lubetkin EI
    Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health utility assessment using EQ-5D among caregivers of children with autism.
    Khanna R; Jariwala K; Bentley JP
    Value Health; 2013; 16(5):778-88. PubMed ID: 23947971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.